Deepak R. Jadon

2.8k total citations
68 papers, 1.3k citations indexed

About

Deepak R. Jadon is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Deepak R. Jadon has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Rheumatology, 52 papers in Immunology and 18 papers in Hematology. Recurrent topics in Deepak R. Jadon's work include Spondyloarthritis Studies and Treatments (54 papers), Psoriasis: Treatment and Pathogenesis (46 papers) and Rheumatoid Arthritis Research and Therapies (34 papers). Deepak R. Jadon is often cited by papers focused on Spondyloarthritis Studies and Treatments (54 papers), Psoriasis: Treatment and Pathogenesis (46 papers) and Rheumatoid Arthritis Research and Therapies (34 papers). Deepak R. Jadon collaborates with scholars based in United Kingdom, United States and Ireland. Deepak R. Jadon's co-authors include Neil McHugh, Eleanor Korendowych, William Tillett, Raj Sengupta, Gavin Shaddick, Charlotte Cavill, Oliver FitzGerald, Alison Nightingale, Mark A. Lindsay and Carmel B. Stober and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Nature Reviews Rheumatology.

In The Last Decade

Deepak R. Jadon

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak R. Jadon United Kingdom 19 937 766 452 91 90 68 1.3k
Renee Perdok United States 13 1.3k 1.4× 1.0k 1.4× 742 1.6× 80 0.9× 55 0.6× 20 1.8k
Silje Watterdal Syversen Norway 17 715 0.8× 222 0.3× 114 0.3× 113 1.2× 84 0.9× 39 1.2k
Ritva Peltomaa Finland 13 345 0.4× 93 0.1× 122 0.3× 74 0.8× 35 0.4× 27 571
Arzu Kaya Türkiye 17 382 0.4× 157 0.2× 145 0.3× 103 1.1× 80 0.9× 40 682
Jian Zhu China 13 481 0.5× 162 0.2× 139 0.3× 119 1.3× 106 1.2× 84 684
Mansoor Karimifar Iran 13 245 0.3× 98 0.1× 57 0.1× 83 0.9× 48 0.5× 49 591
S Yoshino Japan 17 250 0.3× 105 0.1× 90 0.2× 93 1.0× 282 3.1× 43 849
Birgitta Nordmark Sweden 11 541 0.6× 129 0.2× 174 0.4× 32 0.4× 62 0.7× 12 858
Ahmet Omma Türkiye 14 253 0.3× 149 0.2× 84 0.2× 120 1.3× 59 0.7× 103 608
A. Collado Spain 13 469 0.5× 194 0.3× 107 0.2× 109 1.2× 45 0.5× 25 698

Countries citing papers authored by Deepak R. Jadon

Since Specialization
Citations

This map shows the geographic impact of Deepak R. Jadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak R. Jadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak R. Jadon more than expected).

Fields of papers citing papers by Deepak R. Jadon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak R. Jadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak R. Jadon. The network helps show where Deepak R. Jadon may publish in the future.

Co-authorship network of co-authors of Deepak R. Jadon

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak R. Jadon. A scholar is included among the top collaborators of Deepak R. Jadon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak R. Jadon. Deepak R. Jadon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Marion, William Tillett, Deepak R. Jadon, et al.. (2024). The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241240913–1759720X241240913. 1 indexed citations
2.
Ng, Beverly, Deepak R. Jadon, Frank Behrens, et al.. (2023). Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. 50(Suppl 2). 61–65. 1 indexed citations
3.
Foley, Éimear M., Siân Lowri Griffiths, Jack Rogers, et al.. (2023). Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis. BMJ Open. 13(3). e067944–e067944. 8 indexed citations
4.
Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). 3514–3520. 3 indexed citations
5.
Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). e255–e266. 9 indexed citations
6.
Gudu, Tania, et al.. (2022). Improving Imaging Modalities in Early Psoriatic Arthritis: The Role of Ultrasound in Early Diagnosis of Psoriatic Arthritis. Frontiers in Medicine. 8. 804695–804695. 4 indexed citations
7.
Stober, Carmel B., Iain B. McInnes, Soumya Raychaudhuri, et al.. (2022). Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. The Journal of Rheumatology. 49(6 Suppl 1). jrheum.211336–jrheum.211336. 1 indexed citations
8.
Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201675–jrheum.201675. 9 indexed citations
10.
Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201674–jrheum.201674. 17 indexed citations
12.
Poddubnyy, Denis, Deepak R. Jadon, Filip Van den Bosch, Philip J. Mease, & Dafna D. Gladman. (2021). Axial involvement in psoriatic arthritis: An update for rheumatologists. Seminars in Arthritis and Rheumatism. 51(4). 880–887. 57 indexed citations
13.
Tillett, William, Alexander Allen, Laura Tucker, et al.. (2020). Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Lara D. Veeken. 60(4). 1588–1592. 3 indexed citations
14.
Gudu, Tania & Deepak R. Jadon. (2020). Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease. 12. 1759720X20975888–1759720X20975888. 11 indexed citations
15.
Lovell, C. R., Gavin Shaddick, Graham Robinson, et al.. (2019). Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study. The Journal of Rheumatology. 46(9). 1097–1102. 15 indexed citations
16.
Budu‐Aggrey, Ashley, John Bowes, Philip E. Stuart, et al.. (2017). A rare coding allele in IFIH1 is protective for psoriatic arthritis. Annals of the Rheumatic Diseases. 76(7). 1321–1324. 20 indexed citations
17.
Gaston, J. S. Hill & Deepak R. Jadon. (2017). Th17 cell responses in spondyloarthritis. Best Practice & Research Clinical Rheumatology. 31(6). 777–796. 20 indexed citations
18.
Jadon, Deepak R., Gavin Shaddick, William Tillett, et al.. (2015). Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History. The Journal of Rheumatology. 42(7). 1169–1176. 16 indexed citations
19.
Tillett, William, Luisa Costa, Deepak R. Jadon, et al.. (2011). The ClASsification for Psoriatic ARthritis (CASPAR) Criteria – A Retrospective Feasibility, Sensitivity, and Specificity Study: Table 1.. The Journal of Rheumatology. 39(1). 154–156. 121 indexed citations
20.
Smith, J. T., Deepak R. Jadon, Phil McEwan, et al.. (2005). Long‐term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clinical Endocrinology. 63(1). 26–31. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026